reference/1674231

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1674231

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	1022
issn	0006-291X
issueIdentifier	3
pageRange	1017-1022
publicationName	Biochemical and Biophysical Research Communications
startingPage	1017
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0da8dc91ddabc14994538d65ad0769b7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_42eaed73e3bcf1da908e1ebb5d73a128
bibliographicCitation	Yang Z, Chen M, Carter JD, Nunemaker CS, Garmey JC, Kimble SD, Nadler JL. Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes. Biochemical and Biophysical Research Communications. 2006 Jun;344(3):1017–22. doi: 10.1016/j.bbrc.2006.03.177.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5862db112401776fed35cf1f77e4afc8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b74a8fb2e7a474fc0139688da674c377 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c0a3c304fb5fe458d8244e7986f9326 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef18494cbe474efbe762ddde3585f941 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_abfd33ae3abf73c0a73e40097c93897c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c88929dd83f8511e8a9327a5baace3e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eaaa7f3aae809c2a1379a1359bbb4b6b
date	2006-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/16643856 https://doi.org/10.1016/j.bbrc.2006.03.177
isPartOf	https://portal.issn.org/resource/ISSN/0006-291X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1008
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes
discusses	http://id.nlm.nih.gov/mesh/M0016198 http://id.nlm.nih.gov/mesh/M0084266 http://id.nlm.nih.gov/mesh/M0022590 http://id.nlm.nih.gov/mesh/M0006823 http://id.nlm.nih.gov/mesh/M0016238 http://id.nlm.nih.gov/mesh/M0199975
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D050417Q000276 http://id.nlm.nih.gov/mesh/D050417Q000187 http://id.nlm.nih.gov/mesh/D010455Q000008 http://id.nlm.nih.gov/mesh/D010431Q000031 http://id.nlm.nih.gov/mesh/D003922Q000276 http://id.nlm.nih.gov/mesh/D003922Q000188 http://id.nlm.nih.gov/mesh/D014688Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D000077270 http://id.nlm.nih.gov/mesh/D003922Q000473 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D004338 http://id.nlm.nih.gov/mesh/D010431Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56927919 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45588096 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID501254 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7001 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7442 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53396299

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128748421 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127586751 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID315661300

Total number of triples: 60.